NEU neuren pharmaceuticals limited

Ann: H1 2024 financial results, page-14

  1. 3,267 Posts.
    lightbulb Created with Sketch. 752
    H1 2023 financials included the following statement in relation to royalties etc and was not apparent in todays detail as far is I could ascertain.It is simplistic but clear:

    Potential milestone payments and royalties payable to Neuren for NNZ-2591 in Rett and Fragile X are identical to trofinetide milestone payments and royalties in each of the North American and other regions.Neuren retains the worldwide rights to NNZ-2591 in all other indications.
    Kens
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$17.55
Change
0.540(3.17%)
Mkt cap ! $2.211B
Open High Low Value Volume
$17.48 $18.44 $17.40 $16.43M 922.3K

Buyers (Bids)

No. Vol. Price($)
4 2624 $17.53
 

Sellers (Offers)

Price($) Vol. No.
$17.70 1000 1
View Market Depth
Last trade - 16.10pm 07/08/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.